SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_06 - Longitudinal changes in FIB-4 and improvement in fibrosis stage with obeticholic acid: A secondary analysis of FLINT Trial | Dr. A. SanyalView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016LiverMultiScan – quantitative MR imaging for NASH | Rajarshi BanerjeeView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_05 - Validation of multiparametric MRI in the assessment and staging of non-alcoholic fatty liver disease | Dr. P. EddowesView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_04 - Blood-based Protein Biomarkers of NASH | Dr. S. WilliamsView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016NASH and Fibroscan | Raj Vuppalanchi, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Noninvasive imaging methods for assessment of liver damage in NASH | Bachir Taouli, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Methods of MR fat quantification and their pros and cons | Michael Middleton, MD, PhDView Slideset
VideoViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016Management of DAA Failures | Gregory T. Everson, MDView Video
VideoViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016Post-LT Renal Failure and HCV Rx | Peter Ferenci, MDView Video
VideoViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016Obstacles to Treatment: Renal Disease, Ribavirin, DDIs | Michael Charlton, MDView Video
VideoViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016What Are the Treatment Options? | Maria Londoño, MDView Video
VideoViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016Use of HCV+ Donor Grafts | Didier Samuel, MD, PhDView Video
